CEBP:XETRA:XETRA-iShares VII PLC - iShares MSCI EMU USD Hedged ETF Acc (EUR)

ETF | Others |

Last Closing

USD 10.192

Change

+0.11 (+1.07)%

Market Cap

USD 0.20B

Volume

4.01K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-06 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.01 (-0.03%)

USD 446.30B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.01 (+0.06%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.02 (+0.05%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.11 (-0.38%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.06 (+0.22%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.03 (+0.07%)

USD 104.21B
8R80:XETRA Amundi Index Solutions - Amund..

+0.32 (+0.22%)

USD 102.09B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.05 (-0.10%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.76 (-0.71%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-6.12 (-1.00%)

USD 80.38B

ETFs Containing CEBP:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.44% 83% B 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.44% 83% B 78% C+
Trailing 12 Months  
Capital Gain 20.52% 71% C- 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 20.52% 70% C- 71% C-
Trailing 5 Years  
Capital Gain 65.37% 81% B- 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 65.37% 80% B- 78% C+
Average Annual (5 Year Horizon)  
Capital Gain 15.70% 85% B 82% B
Dividend Return 15.70% 84% B 81% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.29% 56% F 65% D
Risk Adjusted Return 139.03% 100% F 100% F
Market Capitalization 0.20B 45% F 40% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.